1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Real-time Estimate Cboe BZX  -  05/24 02:04:51 pm EDT
132.10 USD   -4.01%
12:25pModerna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity
MT
12:13pGLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber
10:48aWALL STREET STOCK EXCHANGE : Snap cut the rally short
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Chile to purchase 2 million Moderna COVID-19 vaccine doses

01/24/2022 | 01:29pm EDT

SANTIAGO, Jan 24 (Reuters) - Chile, which already boasts one of the world's highest COVID-19 vaccination rates, has agreed to purchase 2 million vaccine doses from Moderna Inc, Chilean interim health minister Maria Teresa Valenzuela said on Monday.

Chile has been hailed as a model for its response to the pandemic, relying mainly on vaccines from Pfizer-BioNTech , Sinovac and AstraZeneca for its inoculation program.

"The agreement with Moderna is subject to approval by the Institute of Public Health, which will review the information on safety and efficacy in the coming weeks," said Valenzuela.

The doses will arrive in Chile in three shipments over the next few months, according to the ministry.

Nearly 93% of Chileans 18 years and older have been fully vaccinated and 12.2 million booster shots have been administered among a target population of almost 19 million people.

Chile has begun offering a fourth shot of the coronavirus vaccine, the first country in Latin America and one of the first in the world to offer the extra dose. (Reporting by Fabian Andres Cambero; Writing by Anthony Esposito Editing by Marguerita Choy)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PLC -0.02% 10598 Delayed Quote.22.15%
BIONTECH SE -4.56% 155.92 Delayed Quote.-36.69%
MODERNA, INC. -4.18% 131.915 Delayed Quote.-45.81%
PFIZER, INC. 0.56% 53.175 Delayed Quote.-10.45%
All news about MODERNA, INC.
12:25pModerna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity
MT
12:13pGLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber
10:48aWALL STREET STOCK EXCHANGE : Snap cut the rally short
09:26aRubius Therapeutics Names Noubar Afeyan Chairman; Shares Rise Pre-Bell
MT
09:15aTRANSCRIPT : Moderna, Inc. Presents at UBS Global Healthcare Conference, May-24-2022 09:15..
CI
08:03aMODERNA, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
07:44aModerna testing potential monkeypox vaccines
RE
06:41aModerna CEO to Exercise 2013 Option, Donate Funds to Charity
DJ
01:08aChina's bet on homegrown mRNA vaccines holds back nation
AQ
05/23MODERNA : Statement Regarding Section 1498 Motion
PU
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 069 M - -
Net income 2022 11 501 M - -
Net cash 2022 18 081 M - -
P/E ratio 2022 5,06x
Yield 2022 -
Capitalization 54 740 M 54 740 M -
EV / Sales 2022 1,66x
EV / Sales 2023 3,38x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 137,62 $
Average target price 212,69 $
Spread / Average Target 54,5%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-45.81%54 740
LONZA GROUP AG-27.15%42 618
IQVIA HOLDINGS INC.-27.91%38 497
SEAGEN INC.-9.87%25 649
ICON PUBLIC LIMITED COMPANY-29.74%17 688
CELLTRION, INC.-25.76%16 131